Patent: 9,364,553
✉ Email this page to a colleague
Summary for Patent: 9,364,553
Title: | Synergistic biomolecule-polymer conjugates |
Abstract: | The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies. |
Inventor(s): | Lee; Chyi (Princeton Junction, NJ) |
Assignee: | PEG Biosciences, Inc. (Monmouth Junction, NJ) |
Application Number: | 14/444,555 |
Patent Claims: | see list of patent claims |
Details for Patent 9,364,553
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2026-05-24 |
Horizon Therapeutics Ireland Dac | ACTIMMUNE | interferon gamma-1b | Injection | 103836 | 02/25/1999 | ⤷ Try a Trial | 2026-05-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |